Welcome to LookChem.com Sign In|Join Free

CAS

  • or

136-99-2

Post Buying Request

136-99-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

136-99-2 Usage

Flammability and Explosibility

Nonflammable

Check Digit Verification of cas no

The CAS Registry Mumber 136-99-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,3 and 6 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 136-99:
(5*1)+(4*3)+(3*6)+(2*9)+(1*9)=62
62 % 10 = 2
So 136-99-2 is a valid CAS Registry Number.
InChI:InChI=1/C16H32N2O/c1-2-3-4-5-6-7-8-9-10-11-16-17-12-13-18(16)14-15-19/h19H,2-15H2,1H3

136-99-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,5-dihydro-2-undecyl-1H-imidazole-1-ethanol

1.2 Other means of identification

Product number -
Other names 1-(2-Hydroxyethyl)-2-undecylimidazoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Intermediates,Surface active agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:136-99-2 SDS

136-99-2Downstream Products

136-99-2Relevant articles and documents

Synthesis of Long Chain 2-Alkyl-1-(2-hydroxyethyl)-2-imidazolines under Microwave in Solvent-Free Conditions

Martínez-Palou, Rafael,De Paz, Gerardo,Marín-Cruz, Jesús,Zepeda, Luis Gerardo

, p. 1847 - 1849 (2003)

An efficient method for the synthesis of long chain 2-alkyl-1-(2-hydroxyethyl)-2-imidazolines, and their amide precursors, by condensing aminoethylethanolamine and several fatty acids under non-solvent microwave irradiation using CaO as support, is described. Products were obtained in good yields and high purity in a few minutes, in both multimode microwave and monomode microwave oven. Evidences of non-thermal microwave effects are given.

The inhibition performance of hydroxy lauric imidazoline for mild steel in chloride solution saturated with CO2

Ma, Lan,He, Yi,Luo, Pin Ya,Zhan, Yingqing,Yang, Ran Ran,Zhou, Yanqiu

, p. 304 - 314 (2016/06/13)

In the paper, a novel hydroxy lauric imidazoline (HL-IM) was synthesized using lauric acid and ethylene diamine as raw materials. Methanol reaction method was introduced to prepare the hydroxy lauric imidazoline (HL-IM). According to the results of experiments, the optimum synthesis conditions of methanol reaction was determined through orthogonal experiment, which were: methyl laurate: ethylene diamine = 1: 1, sodium methoxide (0.75 wt %), reaction temperature 100°C, reaction time 2 h. The inhibition efficiency of HL-IM inhibitor was investigated in the condition of 5 wt % NaCl solutions saturated with CO2 at 333.15 K for 72 h. With 150 mg L–1 inhibitor dosage, the efficiency of inhibition reached 90.17% by weight loss method. Through film-forming property, foaming characteristic, and emulsification tendency test, it w a s shown that HL-IM had good water-solubility, a smaller emulsification tendency in 5 wt % NaCl solution, and a little foaming performance. Meanwhile, referring to the polarization curves tests, the synergistic effect of HL-IM with the potassium iodide, methylbutynol, and cetyltrimethyl ammonium bromide was studied.

Compositions and method comprising heterocyclic compounds containing two heteroatoms as membrane penetration enhancers

-

, (2008/06/13)

A method and compositions for enhancing absorption of topically administered physiologically active agents through the skin and mucous membranes of humans and animals in a transdermal device or formulation for local or systemic use, comprising a therapeutically effective amount of a pharmaceutically active agent and a non-toxic, effective amount of penetration enhancing agent of the formula I: STR1 wherein R is a saturated or unsaturated, straight or branched, cyclic or acyclic hydrocarbon group with from 1 to 19 carbon atoms, alkoxyalkyl, haloalkyl, specifically trifluoromethyl, alkoxy, amino, alkylamino and acylamino; R' and R" are hydrogen, alkyl, trifluoromethyl, alkoxyalkyl, aminoalkyl, alkyl- and acylaminoalkyl, carboxy, carbalkoxy, hydroxyalkyl or lower alkyl ester thereof; X is O or NR1 wherein R1 is hydrogen, alkyl, alkenyl, alkoxyalkyl, carbalkoxyalkyl, aminoalkyl, alkyl- and acylaminoalkyl, hydroxyalkyl or hydroxyalkyloxyalkyl and lower alkyl ester thereof; and n is 2 or 3 are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 136-99-2